Back to TD Waterhouse Canada Inc. TD Waterhouse Canada Inc.

NGENNGEN
2 quarters

Position history for TD Waterhouse Canada Inc.TD Waterhouse Canada Inc.'s holdings in NERVGEN PHARMA CORP

TD Waterhouse Canada Inc. holds 23,800 shares of NGEN (NERVGEN PHARMA CORP), worth $49,812 as of 2026-Q2. NGEN represents 0.0% of TD Waterhouse Canada Inc.'s portfolio.

Current Value

$49,812

Current Shares

23,800

Total Value Change

-$53,036

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
23,800
0.0%
$49,8120.0%$2.06
0
2026-Q1
New
23,800
-
$102,8480.0%$3.95
30

Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used